Cargando…
Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme
Administration of 120 mg·kg(−1) α(1)-antitrypsin on a biweekly basis was safe and well tolerated http://ow.ly/CVbz30lUBum
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557539/ https://www.ncbi.nlm.nih.gov/pubmed/30237305 http://dx.doi.org/10.1183/13993003.00897-2018 |
Sumario: | Administration of 120 mg·kg(−1) α(1)-antitrypsin on a biweekly basis was safe and well tolerated http://ow.ly/CVbz30lUBum |
---|